Corcept Therapeutics Inc (CORT)

02:56 AM

Corcept Therapeutics climbs on UBS upgrade - MSN

02:56 AM

May 22, 2026

CORT Stock Price, Quote & Chart | CORCEPT THERAPEUTICS INC (NASDAQ:CORT) - ChartMill

May 22, 2026

May 20, 2026

Affiliate of CORT (NASDAQ: CORT) files Form 144 to offer 5,000 shares - Stock Titan

May 20, 2026

May 19, 2026

Wall Street Analysts Believe Corcept (CORT) Could Rally 43.32%: Here's is How to Trade - Yahoo Finance UK

May 19, 2026

May 18, 2026

Corcept Therapeutics Inc. (CORT) Stock Analysis: Exploring a 40.15% Potential Upside for Biotech Investors - DirectorsTalk Interviews

May 18, 2026

May 15, 2026

Corcept (CORT) chief business officer reports 7,300-share gift of common stock - Stock Titan

May 15, 2026

May 14, 2026

CORT Stock Chart | CORCEPT THERAPEUTICS INC (NASDAQ:CORT) - ChartMill

May 14, 2026

May 13, 2026

UBS upgrades Corcept Therapeutics (CORT) - MSN

May 13, 2026

May 13, 2026

Corcept Therapeutics (CORT) Receives Upgrade, Stock Surges Over 7% - GuruFocus

May 13, 2026

May 13, 2026

Corcept Therapeutics Shares Rise After UBS Upgrade - Moomoo

May 13, 2026

May 13, 2026

UBS Upgrades Corcept Therapeutics(CORT.US) to Buy Rating, Cuts Target Price to $72 - Moomoo

May 13, 2026

May 11, 2026

Corcept Therapeutics (CORT) Stock Analysis: Unveiling a 40% Potential Upside in the Biotech Sector - DirectorsTalk Interviews

May 11, 2026

May 08, 2026

CORT Q1 earnings match estimates, revenues miss, 2026 outlook raised - MSN

May 08, 2026

May 08, 2026

Vanguard Group Inc. Has $330.42 Million Holdings in Corcept Therapeutics Incorporated $CORT - MarketBeat

May 08, 2026

May 07, 2026

Why Corcept Therapeutics Stock Is Sinking Now - TipRanks

May 07, 2026

May 07, 2026

CORT IMPORTANT DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Corcept Therapeutics Incorporated Investors with Losses in Excess of $100K to Secure Counsel Before Important April 21 Deadline in Securities Class ActionCORT - TMX Newsfile

May 07, 2026

May 07, 2026

Corcept (CORT) CDO sells 20K shares under 10b5-1 plan - Stock Titan

May 07, 2026

May 07, 2026

CORT FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Corcept Therapeutics Incorporated Investors with Losses in Excess of $100K to Secure Counsel Before Important April 21 Deadline in Securities Class ActionCORT - TMX Newsfile

May 07, 2026

May 07, 2026

Corcept Therapeutics (CORT) Is Up 11.9% After Q1 Loss, Higher 2026 Outlook And ALS DataHas The Bull Case Changed? - Yahoo Finance

May 07, 2026

May 07, 2026

Corcept (CORT) Q1 2025 Earnings Transcript - AOL.com

May 07, 2026

May 06, 2026

Corcept Must Face Most Teva Mifepristone Antitrust Claims - Law360

May 06, 2026

May 06, 2026

Corcept Therapeutics IncorporatedCommon Stock (NQ: CORT - FinancialContent

May 06, 2026

May 06, 2026

How many employees work at Corcept Therapeutics? - Revelio Labs

May 06, 2026

May 05, 2026

Teva's US exclusive-dealing claims survive Corcept's move to dismiss - MLex

May 05, 2026

May 05, 2026

Corcept (NASDAQ: CORT) CEO sells 40K shares under 10b5-1 plan - Stock Titan

May 05, 2026

May 05, 2026

Corcept Therapeutics (NASDAQ: CORT) affiliate plans sale of 20,000 shares via Stifel - Stock Titan

May 05, 2026

May 05, 2026

Corcept Therapeutics Incorporated (NASDAQ:CORT) Q1 2026 Earnings Call Transcript - Insider Monkey

May 05, 2026

May 05, 2026

CORT Q1 Deep Dive: Early Lifyorli Launch and Endocrinology Momentum Offset Margin Pressures - Yahoo Finance

May 05, 2026

May 05, 2026

Corcept (CORT) Q1 2026 Earnings Transcript - AOL.com

May 05, 2026

May 04, 2026

Corcept Therapeutics Is Maintained at Buy by HC Wainwright & Co. - Moomoo

May 04, 2026

May 04, 2026

CCORF Maintains Corcept Therapeutics(CORT.US) With Buy Rating, Maintains Target Price $110 - Moomoo

May 04, 2026

May 04, 2026

Corcept (CORT) Q2 2025 Earnings Transcript - AOL.com

May 04, 2026

May 04, 2026

Corcept (CORT) Q4 2025 Earnings Transcript - AOL.com

May 04, 2026

May 04, 2026

CORT Maintained by HC Wainwright & Co. -- Price Target Raised to $75 - GuruFocus

May 04, 2026

May 04, 2026

CORT DEADLINE: ROSEN, A LEADING AND TOP RANKED LAW FIRM, Encourages Corcept Therapeutics Incorporated Investors with Losses in Excess of $100K to Secure Counsel Before Important April 21 Deadline in Securities Class ActionCORT - TMX Newsfile

May 04, 2026

May 04, 2026

Corcept Therapeutics Inc. (CORT) Stock Analysis: A 36.91% Upside Potential In Biotech - DirectorsTalk Interviews

May 04, 2026

May 04, 2026

MSN Money - MSN

May 04, 2026

May 03, 2026

symbol__ Stock Quote Price and Forecast - CNN

May 03, 2026

May 02, 2026

Corcept (CORT) Upgraded After Key Regulatory Approval for Lifyorli - Yahoo Finance

May 02, 2026

May 01, 2026

Corcept Therapeutics Shakes Up Nasdaq Index Fund Radar - Kalkine Media

May 01, 2026

May 01, 2026

CORT Maintained by Piper Sandler -- Price Target Raised to $88 - GuruFocus

May 01, 2026

May 01, 2026

Corcept Therapeutics Guides Higher on Lifyorli-Fueled Revenue Growth - The Globe and Mail

May 01, 2026

May 01, 2026

Corcept Therapeutics Is Maintained at Overweight by Piper Sandler - Moomoo

May 01, 2026

May 01, 2026

Corcept Therapeutics (NASDAQ:CORT) Stock Price Up 7.9%Time to Buy? - MarketBeat

May 01, 2026

May 01, 2026

Corcept Therapeutics (CORT) insider notifies sale of 40,000 shares via Stifel - Stock Titan

May 01, 2026

May 01, 2026

CORT Q1 Earnings Match Estimates, Revenues Miss, 2026 Outlook Raised - The Globe and Mail

May 01, 2026

May 01, 2026

Corcept Therapeutics Pivotal Study Shows 87% Lower Death Risk - Benzinga

May 01, 2026

May 01, 2026

Corcept Therapeutics Incorporated Q1 2026 Earnings Call Summary - Yahoo Finance

May 01, 2026

May 01, 2026

Corcept Therapeutics Inc (CORT) Q1 2026 Earnings Call Highlights - GuruFocus

May 01, 2026